Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.

Coustan-Smith, Elaine; Ribeiro, Raul C; Rubnitz, Jeffrey E; Razzouk, Bassem I; Pui, Ching-Hon; Pounds, Stanley; Andreansky, Martin; Behm, Frederick G; Raimondi, Susana C; Shurtleff, Sheila A; Downing, James R; Campana, Dario

Coustan-Smith, Elaine; Ribeiro, Raul C; Rubnitz, Jeffrey E; Razzouk, Bassem I; Pui, Ching-Hon; Pounds, Stanley; Andreansky, Martin; Behm, Frederick G; Raimondi, Susana C; Shurtleff, Sheila A; Downing, James R; Campana, Dario.

Affiliation

Coustan-Smith E; Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.

Br J Haematol ; 123(2): 243-52, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14531905

Subject(s)

Leukemia, Myeloid/diagnosis; Acute Disease; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/analysis; Bone Marrow Cells/pathology; Cell Separation/methods; Child; Child, Preschool; Female; Flow Cytometry/methods; Humans; Immunophenotyping; Infant; Karyotyping; Leukemia, Myeloid/drug therapy; Leukemia, Myeloid/immunology; Male; Neoplasm, Residual; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid Type of study: Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Br J Haematol Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links